Physician Resources

SAMHSA releases new guide on the use of medications for alcohol use disorder


 

References

A new guide on the use of medications to treat patients with alcohol use disorder has been released by the Substance Abuse and Mental Health Services Administration in conjunction with National Alcohol Awareness Month.

The guide provides an overview of four Food and Drug Administration–approved drugs developed to treat alcohol use disorder: disulfiram, oral naltrexone, extended-release injectable naltrexone, and acamprosate. It also discusses how to screen, treat, and monitor patients based on their individual needs.

“Current evidence shows that medications are underused in the treatment of alcohol use disorder,” the agency said in a statement announcing the new guidance. “As the Patient Protection and Affordable Care Act (ACA) continues to be implemented, there is considerable potential for expanding use of medication-assisted treatment to treat alcohol use disorder,” they concluded.

The guide can be found online at http://store.samhsa.gov.

Recommended Reading

Guideline recommends combination therapy for smoking cessation in cancer patients
MDedge Family Medicine
Consequences of cocaine use facilitate impulsiveness-depression relationship
MDedge Family Medicine
Recurrent depression worsens odds of smoking cessation
MDedge Family Medicine
Consider these medications to help patients stay sober
MDedge Family Medicine
AAP against widespread drug testing in high schools
MDedge Family Medicine
Clonidine maintenance therapy extends opioid abstinence
MDedge Family Medicine
Female prisoners with addiction have high rates of comorbid mental disorders
MDedge Family Medicine
Identifying as a nonsmoker may help ex-smokers stay abstinent
MDedge Family Medicine
Executive function deficits linked to e-cigarette use in early adolescents
MDedge Family Medicine
FDA issues new industry guidance for abuse-deterrent opioids
MDedge Family Medicine